LNSR — LENSAR, Inc.

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1320350 ·
Last close
$9.23
Market Cap
$113.40M
52W High
$9.25
52W Low
$4.95
ADV30
146,414
Next earnings
2026-11-12
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 13,428,000 6,382,000 2,239,000 36,332,000 66,223,000 12,494,000 55,433,000
Dec 2025 16,025,000 6,937,000 -4,919,000 -1,458,000 71,430,000 12,974,000 97,449,000
Sep 2025 14,316,000 6,036,000 -7,580,000 -3,713,000 70,204,000 7,637,000 96,111,000
Jun 2025 13,935,000 7,024,000 -6,289,000 -1,764,000 70,414,000 7,150,000 93,466,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-12,164,000
Investing CF
$4,753,000
Financing CF
$358,000
CapEx
$-86,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.58
As of
2026-08-16

Balance + Analyst (yfinance extras)

Retained Earnings
$-141,243,000
Inventory
$23,099,000
Receivables
$5,183,000
ST Investments
$1,001,000
EBIT TTM
$-16,549,000
Pretax Income TTM
$29,397,000
Interest Exp TTM
Analysts
2

Yahoo Snapshot (yfinance, live)

Total Revenue
$60,264,000
EBITDA
$-16,328,000
Free Cash Flow
$-24,391,250
Enterprise Value
$115,998,536
Total Cash
$13,565,000
Total Debt
$2,381,000
Shares Out
12,285,865
Trailing EPS
$0.20
Book Value
$1.21
ROE
357.3%
ROA
-18.7%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 58,435,000 -24,578,000 -34,280,000 71,430,000 97,449,000 -14,831,000
Dec 2024 53,494,000 -6,936,000 -31,404,000 66,297,000 61,435,000 -2,275,000
Dec 2023 42,164,000 -12,229,000 -14,383,000 69,585,000 36,156,000 -9,659,000
Dec 2022 35,358,000 -20,177,000 -19,914,000 55,844,000 13,860,000 -14,856,000

TTM Snapshot

Revenues TTM
$12,636,000
NetIncome TTM
$-9,043,000
OpCashFlow TTM
$0
Assets (Latest)
$66,297,000
Forward EPS
$-0.71

Peers — same industry

TickerNameMarket CapLastDaily %
LAKE LAKELAND INDUSTRIES INC $112.31M $11.38
SPAI Safe Pro Group Inc. $109.35M $5.37
GUTS FRACTYL HEALTH, INC. $119.38M $0.75
VANI Vivani Medical, Inc. $124.48M $1.38
PYPD PolyPid Ltd. $101.25M $4.99

News headlines (Yahoo Finance, 1h cache)

LENSAR (LNSR) Q2 2026 Earnings Call Transcript
2026-08-20 14:13 · Yahoo
LENSAR Inc (LNSR) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability Surge
2026-08-13 23:07 · Yahoo
LENSAR Q2 Earnings Call Highlights
2026-08-13 17:04 · Yahoo
LENSAR® Reports Second Quarter 2026 Results and Provides Business Update
2026-08-13 11:00 · Yahoo
LENSAR® to Report Second Quarter 2026 Results on August 13th, 2026
2026-08-06 12:00 · Yahoo
Lensar (LNSR) Q1 2026 Earnings Transcript
2026-06-01 17:10 · Yahoo
Lensar (LNSR) Q4 2025 Earnings Transcript
2026-06-01 17:10 · Yahoo
LENSAR Q1 Earnings Call Highlights
2026-05-08 18:20 · Yahoo
LENSAR® Reports First Quarter 2026 Results and Provides Business Update
2026-05-08 11:00 · Yahoo
LENSAR® to Report First Quarter 2026 Results on May 8, 2026
2026-04-30 11:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.